公开(公告)号：US20070082873A1

公开(公告)日：2007-04-12

申请号：US10577196

申请日：2004-10-27

申请人： Kurt Lingenhöhl ,  Ference Martenyi ,  Silvio Ofner ,  Mary Karolchyk ,  Hans Kalkman

发明人： Kurt Lingenhöhl ,  Ference Martenyi ,  Silvio Ofner ,  Mary Karolchyk ,  Hans Kalkman

IPC分类号： A61K31/675

CPC分类号： A61K45/06 ,  A61K31/675 ,  A61K2300/00

摘要： The present invention relates to combinations suitable for the treatment of psychiatric/neurological disorders, in particular schizophrenia. The combinations comprise at least one AMPA receptor antagonist and at least one compound selected from the group consisting of (a) anti-epileptic drugs selected from barbiturates and derivatives thereof, benzodiazepines, carboxamides, hydantoins, succinimides, valproic acid and other fatty acid derivates and other anti-epileptic drugs, (b) conventional antipsychotics and (c) atypical antipsychotics.

摘要翻译： 本发明涉及适用于治疗精神病/神经障碍，特别是精神分裂症的组合。 所述组合包含至少一种AMPA受体拮抗剂和至少一种选自（a）选自巴比妥类及其衍生物，苯并二氮杂，甲酰胺，乙内酰脲，琥珀酰亚胺，丙戊酸和其它脂肪酸衍生物的抗癫痫药物的化合物和 其他抗癫痫药，（b）常规抗精神病药和（c）非典型抗精神病药。